Nephrocare Health Services P/E Ratio
Current P/E Ratio
93.56
High Valuation
Very High - High growth expectations or significantly overvalued
Nephrocare Health Services (NEPHROPLUS) P/E ratio is 93.56 (High), EPS (TTM) ₹8.48, current price ₹699.10 on NSE — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see NEPHROPLUS share price.
Current Valuation Metrics
P/E Ratio
93.56
Current Price
₹699.10
EPS (TTM)
₹8.48
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
95.77
Sector Median
41.87
Sector Rank
#11 of 57
Sector Percentile
19.3%
Earnings Breakdown (TTM)
TTM EPS
₹8.15
Mar 2026
₹3.03
Jun 2026
₹3.19
NEPHROPLUS P/E Ratio — Valuation Signal & Historical Context
Nephrocare Health Services P/E 93.56 — signal: Overvalued. See Nephrocare Health Services P/B valuation to compare market price against book value per share.
- Stock appears overvalued with PE of 93.56, suggesting caution for new investments
NEPHROPLUS vs Healthcare Services Peers — P/E Ratio Comparison
Nephrocare Health Services P/E 93.56 vs Healthcare Services average 95.77, median 41.87 — range 8.81–1652.14.
Sector Average
95.77
Sector Median
41.87
Lowest P/E
8.81
Highest P/E
1652.14
Companies
57
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 8.81 | ₹167 | Low |
| Abate AS Industries | ABATEAS | 11.54 | ₹140 | Low |
| Deccan Health Care | DECCAN | 12.09 | ₹32 | Low |
| Nidan Labs & Healthcare | NIDAN | 12.27 | ₹19 | Low |
| Shanmuga Hospital | SHANMUGA | 14.27 | ₹64 | Low |
| One Global Service Provi… | ONEGLOBAL | 16.82 | ₹1,163 | Moderate |
| 3B BlackBio DX | 3BBLACKBIO | 17.91 | ₹986 | Moderate |
| Indraprastha Medical Cor… | INDRAMEDCO | 18.19 | ₹3,390 | Moderate |
| Krsnaa Diagnostics | KRSNAA | 18.59 | ₹1,752 | Moderate |
| Sangani Hospitals | SANGANI | 18.94 | ₹70 | Moderate |